Asymmetric [4 + 2] annulation of 5H-thiazol-4-ones with a chiral dipeptide-based Brønsted base catalyst.
Bo ZhuShuai QiuJiangtao LiMichelle L CooteRichmond LeeZhiyong JiangPublished in: Chemical science (2016)
Versatile synthetic strategies that access diverse chemical substrates in a highly chemo- and stereo-selective manner are crucial but demanding. Construction of chiral molecules with multiple (hetero)-quaternary carbon stereocenters in a single fashion is a particularly significant challenge, with important applications in the synthesis of a range of bioactive compounds containing the 1,4-sulfur bridged piperidinone structural motif. The asymmetric synthesis of these entities is complicated due to the need to build at least two hetero-quaternary stereocenters concurrently. In order to achieve this, we have developed a new family of dipeptide-based multifunctional Brønsted base organocatalysts that are highly capable of the first asymmetric [4 + 2] annulation reaction of 5H-thiazol-4-ones with electron-deficient alkenes. This protocol could be applied to a series of alkenes such as nitroalkenes, 4-oxo-4-arylbutenones, 4-oxo-4-arylbutenoates and methyleneindolinones, providing an efficient approach to valuable chiral 1,4-sulfur bridged piperidinones and their derivatives with multiple hetereo-quaternary stereogenic centers in high yields and enantioselectivities. Density functional theory studies involving 5H-thiazol-4-one and nitroolefin catalysis propose stereochemical insights into the origin of enantio- and chemo-selectivity.
Keyphrases
- density functional theory
- ionic liquid
- capillary electrophoresis
- cancer therapy
- photodynamic therapy
- molecular dynamics
- solid state
- drug delivery
- randomized controlled trial
- locally advanced
- room temperature
- combination therapy
- metal organic framework
- reduced graphene oxide
- visible light
- case control
- rectal cancer
- carbon dioxide